<DOC>
	<DOCNO>NCT02839811</DOCNO>
	<brief_summary>The COBIOPHAD project target development highly sensitive , selective , multiplexed diagnostic device provide quick inexpensive vitro test address prevalent drug hypersensitivity betalactams antibiotic , ( BLCs ) . During retrospective study , BLC structure involve drug hypersensitivity identify serum allergic patient ( versus control ) couple device . A prospective study perform recruitment sample correspond patient know IgE hypersensitivity BLCs base result allergy test clinical history . Controls include : non-allergic individual know tolerance betalactams . The sample use validation COBIOPHAD device real setting .</brief_summary>
	<brief_title>Medical Device Drug Allergy Diagnosis</brief_title>
	<detailed_description />
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Drug Hypersensitivity</mesh_term>
	<criteria>patient know hypersensitivity BLC ( proven mean vivo test ) ( case ) patient contraindication BLC allergy workup patient refusal enter study vulnerable patient accord French regulation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Betalactams</keyword>
	<keyword>In vitro diagnosis</keyword>
</DOC>